World's Best Scientists 2026 revealed!
Jean-Claude Tardif

Jean-Claude Tardif

D-Index & Metrics

Medicine

D-Index
125
Citations
86557
World Ranking
3016
National Ranking
124

Overview

Jean-Claude Tardif is affiliated with the Montreal Heart Institute in Canada and has a significant body of research in medicine, particularly within cardiology and cardiovascular medicine. Their published work spans multiple related subfields, including molecular biology, surgery, radiology, nuclear medicine and imaging, and endocrinology, diabetes, and metabolism.

Their research topics focus primarily on cardiovascular health and disease mechanisms. Key areas include lipoproteins and cardiovascular health, atrial fibrillation management and outcomes, inflammasome and immune disorders, cardiac imaging and diagnostics, cardiovascular function and risk factors, genetic associations and epidemiology, and fatty acid research and health.

Recent papers reflect ongoing research in cardiovascular disease and genetics, with publications listed as follows:

  • Lipoprotein(a) Reduction in Persons with Cardiovascular Disease, 2020, New England Journal of Medicine
  • The Polygenic and Monogenic Basis of Blood Traits and Diseases, 2020, Cell
  • Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations, 2020, Cell
  • Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease, 2020, European Heart Journal
  • Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT), 2020, European Heart Journal

The scientist frequently publishes in several leading journals, notably:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Circulation
  • European Heart Journal
  • Journal of the American College of Cardiology
  • Canadian Journal of Cardiology

Tardif collaborates regularly with a group of coauthors, including Marie-Pierre Dubé, Philippe Gabríel Steg, Christie M. Ballantyne, Eliot A. Brinton, and Deepak L. Bhatt.

Their extensive experience and publication record contribute to research advancements in cardiovascular medicine, with a strong emphasis on the genetic and inflammatory components influencing cardiovascular disease outcomes.

Best Publications

  • Effects of Torcetrapib in Patients at High Risk for Coronary Events

    Philip J. Barter;Mark Caulfield;Mats Eriksson;Scott M Grundy

  • Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

    Elizabeth K. Speliotes;Elizabeth K. Speliotes;Cristen J. Willer;Sonja I. Berndt;Keri L. Monda

  • Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

    Steven E. Nissen;Stephen J. Nicholls;Ilke Sipahi;Peter Libby

  • Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

    Deepak L. Bhatt;P. Gabriel Steg;Michael Miller;Eliot A. Brinton

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

    Gregory G. Schwartz;Anders G. Olsson;Markus Abt;Christie M. Ballantyne

  • Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

    Jean-Claude Tardif;Simon Kouz;David D. Waters;Olivier F. Bertrand

  • Defining the role of common variation in the genomic and biological architecture of adult human height

    Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam

  • Resting heart rate in cardiovascular disease.

    Kim Fox;Jeffrey S. Borer;A. John Camm;Nicolas Danchin

  • Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

    E. K. Speliotes;C. J. Willer;S. I. Berndt;K. L. Monda

  • Effect of Torcetrapib on the Progression of Coronary Atherosclerosis

    Steven E. Nissen;Jean Claude Tardif;Stephen J. Nicholls;James H. Revkin

  • Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease

    Ariel Diaz;Martial G. Bourassa;Marie-Claude Guertin;Jean-Claude Tardif

  • Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.

    J C Tardif;G Cöté;J Lespérance;M Bourassa

  • Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.

    Emmanuelle Vermes;Jean-Claude Tardif;Martial G. Bourassa;Normand Racine

  • Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.

    Jocelyn Dupuis;Jean-Claude Tardif;Peter Cernacek;Pierre Théroux

  • Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.

    Tsimikas S;Karwatowska-Prokopczuk E;Gouni-Berthold I;Tardif Jc

  • Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

    Jean-Claude Tardif;Ian Ford;Michal Tendera;Martial G. Bourassa

  • Effects of hormone replacement therapy and antioxidant Vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial

    David D. Waters;Edwin L. Alderman;Judith Hsia;Barbara V. Howard

  • Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

    Jean-Claude Tardif;Jean Grégoire;Philippe L. L’Allier;Reda Ibrahim

  • Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis

    Steven E. Nissen;Stephen J. Nicholls;Ilke Sipahi;Peter Libby

Frequent Co-Authors

Marie-Pierre Dubé
Marie-Pierre Dubé Montreal Heart Institute
Ian Ford
Ian Ford University of Glasgow
Stanley Nattel
Stanley Nattel Montreal Heart Institute
Roberto Ferrari
Roberto Ferrari University of Ferrara
Guillaume Lettre
Guillaume Lettre Montreal Heart Institute
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Mario Talajic
Mario Talajic Montreal Heart Institute
Tonu Esko
Tonu Esko University of Tartu
J. Wouter Jukema
J. Wouter Jukema Leiden University Medical Center
Alexander P. Reiner
Alexander P. Reiner University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to many fields in healthcare beyond the traditional path of becoming a physician. Online degree programs now offer flexible and affordable options for students interested in advancing their healthcare careers from anywhere in the world.

For those looking at leadership roles in hospitals or clinics, cheapest mha programs online provide a cost-effective path to a Master’s in Healthcare Administration. If you're seeking more options, there are also many online mha programs affordable that help students learn about healthcare management, policy, and finance.

Nurses aiming for advanced practice roles can benefit from enrolling in the best online bsn to dnp programs, which equip graduates for leadership, research, and specialized clinical positions. Similarly, those interested in pharmaceutical care should consider pharmd online programs to become qualified pharmacists.

Each of these online pathways allows aspiring healthcare professionals to balance their studies with work and life, making it easier to achieve their academic and career goals.

Best Scientists Citing Jean-Claude Tardif

Trending Scientists

Recently Published Articles